Peptidomics

Nutrigenomics and Proteomics in Health and Disease: Food Factors and Gene Interactions

Volumn , Issue , 2009, Pages 375-386

  Mine, Yoshinori ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Affinity peptidomics and affinity peptidomics approach; Affinity peptidomics and combinatorial peptidomics; MALDI TOF MS; mass spectrometry analytical techniques allowing sensitive and precise detection of total peptide content in complex mixtures; NANOLC ESI TOF MS; peptide biomarkers in diseases peptide role in physiological processes regulated by proteolytic control; Peptide detection and peptide quantification; Peptides short polymers of amino acids linked by peptide bonds; Peptidomics; Peptidomics technologies

Indexed keywords

EID: 84886474031     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813807263.ch26     Document Type: Chapter

References (64)

1. Adermann K, John H, Standker L, and Forssmann WG. 2004. Exploiting natural peptide diversity: Novel research tools and drug leads. Curr Opin Biotechnol. 15:599-606.
2. Aebersold R and Mann M. 2003. Mass spectrometry-based proteomics. Nature. 422:198-207.
3. Afman L and Muller M. 2006. Nutrigenomics: From molecular nutrition to prevention of disease. J Am Diet Assoc. 106:569-576.
4. Ashcroft AE. 2003. Protein and peptide identification: The role of mass spectrometry in proteomics. Nat Prod Rep. 20(2):202-215.
5. Baggerman G, Verleyen P, Clynen E, Huybrechts J, De Loof A, and Schoofs L. 2004. Peptidomics. J Chromatogr B Analyt Technol Biomed Life Sci. 803(1):3-16.
6. Barnouin K. 2004. Two-dimensional gel electrophoresis for analysis of protein complexes. Methods Mol Biol. 261:479-498.
7. Beavis RC and Chait BT. 1990. High-accuracy molecular mass determination of proteins using matrix-assisted laser desorption mass spectrometry. Anal Chem. 62(17):1836-1840.
8. Boonen K, Landuyt B, Baggerman G, Husson SJ, Huybrechts J, and Schoofs L. 2008. Peptidomics: The integrated approach of MS, hyphenated techniques and bioinformatics for neuropeptide analysis. J Sep Sci. 31(3):427-445.
9. Che FY and Fricker LD. 2005. Quantitative peptidomics of mouse pituitary: Comparison of different stable isotopic tags. J Mass Spectrom. 40:238-249.
10. Che FY, Lim J, Biswas R, Pan H, and Fricker LD. 2005. Quantitative neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol Cell Proteomics. 4:1391-1405.
11. Che FY, Yuan Q, Kalinina E, and Fricker LD. 2004. Examination of the rate of peptide biosynthesis in neuroendocrine cell lines using a stable isotopic label and mass spectrometry. J Neurochem. 90:585-594.
12. Clynen E, Baggerman G, Veelaert D, Cerstiaens A, Van Der Horst D, Harthoorn L, Derua R, Waelkens E, De Loof A, and Schoofs L. 2001. Peptidomics of the pars intercerebralis-corpus cardiacum complex of the migratory locust, Locusta migratoria. Eur J Biochem. 268(7):1929-1939.
13. Clynen E, De Loof A, and Schoofs L. 2003. The use of peptidomics in endocrine research. Gen Comp Endocrinol. 132(1):1-9.
14. Davis CD and Milner JA. 2007. Biomarkers for diet and cancer prevention research: Potentials and challenges. Acta Pharmacol Sin. 28(9): 1262-1273.
15. Dorsey ER, Holloway RG, and Ravina BM. 2006. Biomarkers in Parkinson's disease. Expert Rev Neurother. 6:823-831.
16. Eipper BA, Mains RE, and Herbert E. 1986. Peptides in the nervous sytem. Trends Neurosci. 9:463-468.
17. Fricker LD. 2007. Neuropeptidomics to study peptide processing in animal models of obesity. Endocrinology. 148(9):4185-4190.
18. Fricker LD, Lim J, Pan H, and Che FY. 2006. Peptidomics: Identification and quantification of endogenous peptides in neuroendocrine tissues. Mass Spectrom Rev. 25(2):327-344.
19. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, and Aebersold R. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 17(10):994-999.
20. Heine G, Zucht HD, Schuhmann MU, Bürger K, Jürgens M, Zumkeller M, Schneekloth CG, Hampel H, Schulz-Knappe P, and Selle H. 2002. High-resolution peptide mapping of cerebrospinal fluid: A novel concept for diagnosis and research in central nervous system diseases. J Chromatogr B Analyt Technol Biomed Life Sci. 782(2002): 353-361.
21. Herrero M, Ibañez E, and Cifuentes A. 2008. Capillary electrophoresis-electrospray-mass spectrometry in peptide analysis and peptidomics. Electrophoresis. 29(10):2148-2160.
22. Hökfelt T, Broberger C, Xu ZQ, Sergeyev V, Ubink R, and Diez M. 2000. Neuropeptides-An overview. Neuropharmacology. 39(8):1337-1356.
23. Issaq HJ, Chan KC, Janini GM, Conrads TP, and Veenstra TD. 2005. Multidimensional separation of peptides for effective proteomic analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 817(1):35-47.
24. Julka S and Regnier F. 2004. Quantification in proteomics through stable isotope coding: A review. J Proteome Res. 3(3):350-363.
25. Kelleher NL. 2004. Top-down proteomics. Anal Chem. 76(11):197A-203A.
26. Kirkpatrick DS, Gerber SA, and Gygi SP. 2005. The absolute quantification strategy: A general procedure for the quantification of proteins and post-translational modifications. Methods. 35:265-273.
27. Köllisch GV, Lorenz MW, Kellner R, Verhaert RD, and Hoffmann KH. 2000. Structure elucidation and biological activity of an unusual adipokinetic hormone from corpora cardiaca of the butterfly, Vanessa cardui. Eur J Biochem. 267(17):5502-5508.
28. Lévesque L, Ozdemir V, Gremmen B, and Godard B. 2008. Integrating anticipated nutrigenomics bioscience applications with ethical aspects. OMICS. 12(1):1-16.
29. Lim J, Berezniuk I, Che FY, Parikh R, Biswas R, Pan H, and Fricker LD. 2006. Altered neuropeptide processing in prefrontal cortex of Cpefat/fat mice: Implications for neuropeptide discovery. J Neurochem. 96:1169-1181.
30. Mann M, and Jensen ON. 2003. Proteomic analysis of post-translational modifications. Nat Biotechnol. 21(3):255-261.
31. Mohring T, Kellmann M, Jurgens M, and Schrader M. 2005. Top-down identification of endogenous peptides up to 9 kDa in cerebrospinal fluid and brain tissue by nanoelectrospray quadrupole time-of-flight tandem mass spectrometry. J Mass Spectrom. 40:214-226.
32. O'Donohye TL, Handelmann GE, Miller RL, and Jacobowitz DM. 1982. N-Acetylation regulates the behavioral activity of alpha-melanotropin in a multineurotransmitter neuron. Science. 215(4536):1125-1127.
33. Oosterkamp AJ, Gelpí E, and Abian J. 1998. Quantitative peptide bioanalysis using column-switching nano liquid chromatography/mass spectrometry. J Mass Spectrom. 33(10):976-983.
34. Overall CM and Dean RA. 2006. Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev. 25(1):69-75.
35. Pan H, Che FY, Peng B, Steiner DF, Pintar JE, and Fricker LD. 2006. The role of prohormone convertase-2 in hypothalamic neuropeptide processing: A quantitative neuropeptidomic study. J Neurochem. 98:1763-1777.
36. Phillips CM, Tierney AC, and Roche HM. 2008. Gene-nutrient interactions in the metabolic syndrome. J Nutrigenet Nutrigenomics. 1:136-151.
37. Prigge ST, Mains RE, Eipper BA, and Amzel LM. 2000. New insights into copper monooxygenases and peptide amidation: Structure, mechanism and function. Cell Mol Life Sci. 57(8-9):1236-1259.
38. Reyzer ML and Caprioli RM. 2005. MALDI mass spectrometry for direct tissue analysis: A new tool for biomarker discovery. J Proteome Res. 4(4):1138-1142.
39. Rubin H. 2005. Systemic effects of cancer: Role of multiple proteases and their toxic peptide products. Med Sci Monit. 11:RA221-RA228.
40. Saz JM and Marina ML. 2008. Application of microand nano-HPLC to the determination and characterization of bioactive and biomarker peptides. J Sep Sci. 31(3):446-458.
41. Schoofs L, Veelaert D, Vanden Broeck J, and De Loof A. 1997. Peptides in the locusts, Locusta migratoria and Schistocerca gregaria. Peptides. 18(1):145-156.
42. Schrader M and Selle H. 2006. The process chain for peptidomic biomarker discovery. Dis Markers. 22(1-2):27-37.
43. Schulte I, Tammen H, Selle H, and Schulz-Knappe P. 2005. Peptides in body fluids and tissues as markers of disease. Expert Rev Mol Diagn. 5: 145-157.
44. Schulz-Knappe P, Raida M, Meyer M, Quellhorst EA, and Forssmann WG. 1996. Systematic isolation of circulating human peptides: The concept of peptide trapping. Eur J Med Res. 1(5):223-236.
45. Schulz-Knappe P, Zucht HD, Heine G, Jürgens M, Hess R, and Schrader M. 2001. Peptidomics: The comprehensive analysis of peptides in complex biological mixtures. Comb Chem High Throughput Screen. 4(2):207-217.
46. Scrivener E, Barry R, Platt A, Calvert R, Masih G, Hextall P, Soloviev M, and Terrett J. 2003. Peptidomics: A new approach to affinity protein microarrays. Proteomics. 3(2):122-128.
47. Sewald N and Jakubke HD. 2002. Peptides: Chemistry and Biology, 1st reprint 2003 edition, Wiley-VCH Verlag GmbH: Weinheim, Germany.
48. Sigafoos J, Chestnut WG, Merrill BM, Taylor LC, Diliberto, Jr, EJ, and Viveros OH. 1993. Novel peptides from adrenomedullary chromaffin vesicles. J Anat. 183(Pt 2):253-264.
49. Smith RD. 2002. Trends in mass spectrometry instrumentation for proteomics. Trends Biotechnol. 20(12):S3-S7.
50. Soloviev M, Barry R, Scrivener E, and Terrett J. 2003. Combinatorial peptidomics: A generic approach for protein expression profiling. J Nanobiotechnol. 1(1):4.
51. Soloviev M and Finch P. 2005. Peptidomics, current status. J Chromatogr B Analyt Technol Biomed Life Sci. 815(1-2):11-24.
52. Strand FL. 2003. Neuropeptides: General characteristics and neuropharmaceutical potential in treating CNS disorders. Prog Drug Res. 61: 1-37.
53. Sunderland T, Hampel H, Takeda M, Putnam KT, and Cohen RM. 2006. Biomarkers in the diagnosis of Alzheimer's disease: Are we ready?. J Geriatr Psychiatry Neurol. 19:172-179.
54. Tammen H, Zucht HD, and Budde P. 2007. Oncopeptidomics: A commentary on opportunities and limitations. Cancer Lett. 249(1):80-86.
55. Tanaka K, Waki H, Ido Y, Akita S, Yoshida Y, and Yoshida T. 1988. Protein and polymer analyses up to m/z 100,000 by laser ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 2:151-153.
56. Tatemoto K and Mutt V. 1978. Chemical determination of polypeptide hormones. Proc Natl Acad Sci U S A. 75(9):4115-4119.
57. Torfs P, Baggerman G, Meeusen T, Nieto J, Nachman RJ, Calderon J, De Loof A, and Schoofs L. 2002. Isolation, identification, and synthesis of a disulfated sulfakinin from the central nervous system of an arthropod the white shrimp Litopenaeus vannamei. Biochem Biophys Res Commun. 299(2):312-320.
58. Uttenweiler-Joseph S, Moniatte M, Lagueux M, Van Dorsselaer A, Hoffmann JA, and Bulet P. 1998. Differential display of peptides induced during the immune response of Drosophila: A matrix-assisted laser desorption ionization time-of-flight mass spectrometry study. Proc Natl Acad Sci U S A. 95(19):11342-11347.
59. Verhaert P, Uttenweiler-Joseph S, de Vries M, Loboda A, Ens W, and Standing KG. 2001. Matrix-assisted laser desorption/ionization quadrupole time-of-flight mass spectrometry: An elegant tool for peptidomics. Proteomics. 1(1):118-131.
60. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, and Baumgartner-Parzer S. 2005. Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid. 15:1267-1272.
61. Whicher J, Bienvenu J, and Monneret G. 2001. Procalcitonin as an acute phase marker. Ann Clin Biochem. 38:483-493.
62. Wilm M and Mann M. 1996. Analytical properties of the nanoelectrospray ion source. Anal Chem. 68(1):1-8.
63. Wulfkuhle JD, Paweletz CP, Steeg PS, Petricoin EF, and Liotta L. 2003. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv Exp Med Biol. 532:59-68.
64. Yates JR. 1998. Mass spectrometry and the age of the proteome. J Mass Spectrom. 33(1):1-19.